Xgene Pharmaceutical Inc. develops potent medications for neurological conditions with unmet needs. Their innovation lies in proprietary linker technology, creating dual-acting conjugates that combine two effective therapeutic molecules. This approach generates targeted multimodal therapies where the conjugated prodrug molecules demonstrate modified absorption, pharmacokinetic, and metabolic profiles compared to their individu...
Xgene Pharmaceutical Inc. develops potent medications for neurological conditions with unmet needs. Their innovation lies in proprietary linker technology, creating dual-acting conjugates that combine two effective therapeutic molecules. This approach generates targeted multimodal therapies where the conjugated prodrug molecules demonstrate modified absorption, pharmacokinetic, and metabolic profiles compared to their individual parent drugs. This novel strategy aims to enhance therapeutic efficacy and address complex challenges in neurological care.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.